Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019

Enanta Pharma (ENTA) Tops Q1 EPS by 10c, Revenues Miss

February 6, 2020 4:01 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $0.65, $0.10 better than the analyst estimate of $0.55. Revenue for the quarter came in at $52.6 million versus the consensus estimate of $58.07 million.

We achieved the first of our 2020 milestones with todays announcement of positive data in healthy... More